European Journal of General Medicine Medical Investigations Society ISSN: 1304-3897 Vol. 5, Num. 3, 2008, pp. 178-180

European Journal of General Medicine, Vol. 5, No. 3, 2008, pp. 178-180

Hypochromic Microcytic Anemia In Northwestern Of Tabriz, Iran

Susan Kolahi, Halea Farzin, Manouchehr Khoshbaten

Tabriz University, Faculty of Medicine, Drug Applied Research Center, Tabriz, Iran
Correspondence: Susan Kolahi, Assistant Professor of Rheumatology- Drug Applied Research Center-Tabriz University of Medical Sciences - Iran. E-mail:susan.kolahi@gmail.com

Code Number: gm08034

Aim: Hypochromic microcytic anemia included iron Deficiency Anemia (IDA) and thalassemia is a worldwide problem with easy treatment and important unwanted symptoms that widely prevalent in Iran.
Methods: Present study was undertaken to find prevalence of hypochromic microcytic anemia in Tabriz, Iran. Citizen of Tabriz were taken up for study after they gave a written consent. Subjects were given a questionnaire to elicit anemia related symptoms. Blood counts were done by electronic counter and serum ferritin was assayed by Elisa ,MCV(Mean Cell Volume),MCH (Mean Cell Hb), hemoglobin electrophoresis and TIBC (Total Iron Binding Capacity) were done .
Results: Prevalence of anemia, iron deficiency anemia and minor thalasemia in women was 9.7%, 7%, 1%, respectively, and in men was 9.7%, 2%, 5%.
Conclusion: There was not any significant association between MCV and sex. IDA was more common in women and minor thalasemia was more common in men

Key words: Anemia, hypochromic microcytic anemia, Iron deficiency anemia, minor thalassemia, Iran

Iron deficiency anemia (IDA) has worldwide prevalence (1). IDA has 5% prevalence in the world , but in developing country it is 18% among adult women and 10% in adult men (2,3,6). IDA is an end stage of negative iron balance. It is preceded by a stage of latent iron deficiency (ID) where serum ferritin is below 15.0 ng/ml with normal Hb level (4). It would be interesting to see the prevalence of ID in addition to IDA. Mild anemia is asymptomatic or cause non-specific symptoms. In IDA, besides Hb, MCV and MCH are also reduced. In recent years the prevalence of IDA reduced in Iran because of early diagnosis and early and cheap iron therapy.

Thalassemia is a congenital disease; Iran lies on thalassemic region of the world, and the prevalence of thalasemia is 2.3% in Iran (5). Anemia causes paleness, heart palpitation, tinnitus, headache, agitation and fatigue (2,6). Upon these unwanted symptoms of anemia and the high prevalence of this disease in Iran we used to report the prevalence of hypochromic microcytic anemia in Iran. Women were already anemic at the time of conception, with an estimated prevalence of anemia of 43% in nonpregnant women in developing countries and of 12% in women in wealthier regions (7).

MATERIAL AND METHODS

3035 households (1623 female and 1412 male) were studied after obtaining their informed consent. None of subjects involved in the study had been on any hematinic drugs in last six months or had any infection in past one month. A questionnaire was given to assess symptoms due to anemia. Arbitrary score was assigned according to the response to the questionnaire. Citrated blood samples were being assessed with Technican H₁ (USA) for Hb, Hct and MCV. If Hb in male were being under 13.5 mg/dlit or being under 12 mg/dlit in non pregnant female, we get 5cc blood to assess their serum iron, TIBC, ferritin and retic count .Serum iron, TIBC and ferritin were being analyzed by Tris kit (Australia) and Hitachi 704 autoanalyser system (Germany) in referral laboratory. If there wasn’t any evidence of IDA; blood samples with MCV under 80 were being studied for Hb electrophoresis with Hellena kits in Hellena set (France). Whenever blood sample’s Ferritin was under 15nanogram/millit we defined them as IDA (1). Minor thalassemia defined as Hb A₂ up to two folds or higher, or increasing of HbF (5).

RESULTS

3035 of households completed the study and were available for repeat blood test. Data of these 3035 subjects was analyzed. 1623 (53.4%) subjects were female. Mean age was 33 years (range 16-49). 1412 subjects were male (46.5%). 9.7% of understudy people were anemic. Results of baseline studies are shown in Table 1. Prevalence of IDA and minor thalassemia in female and IDA and minor thalassemia in male were 7%,1%, 2% and 5%, respectively. Among patients who categorized as IDA, in 82% of these patients MCV was under 80 and 56% of them were infected by parasites. In female who categorized as IDA, mean of ferritin was 6.1±2.8 and in male was 5.1±1.8. Transferin saturation percent was less than 16% in 87.3% of IDA patients and was more than 16% in 12.6% of them. Only in 1.2 % of subjects MCV was lower than 80 without any evidence of IDA or thalasemia; but 34% of these patients had hypoferritinemia; and in the rest of them we couldn’t find any reason. In all patients with minor thalassemia MCV/RBC index was lower than 13.

DISCUSSION

In this study the prevalence of anemia was 9.7% in male and female who had entered the study. In one study the prevalence of anemia was 11.5% (12.7% in female and 10% in male) and in 90% of cases the IDA was the reason of anemia (2). In our study prevalence of IDA and minor thalassemia in female and IDA in and minor thalassemia in male were 7%,1%, 2% and 5%, respectively. This study conclude that IDA was the reason of 75% of anemia. Existing the following study by men more than women might be the reason of the high prevalence of thalassemia in this study. Only in 82% of IDA patients MCV was lower than 80 and in all thalassemic patients MCV/RBC index was lower than 13; these findings was in agree with that was in previous study (8,9,10). In 87.3% of IDA patients transferrine saturation percent was lower than 16. As point as different theories about the relationships between transferrin saturation percent and IDA ;there isn’t high specificity for transferrine saturation percent test to determine IDA (11). On the other hand, iron deficiency is widespread among females in Iran as shown by this study; but anemia decreases, perhaps due to hematinic therapy like other countries. Then this problem must be overemphasized by public health system, because of too easy and available treatment and nutrition education for people. Our people don’t know that which foods to eat and what foods help their health.

REFERENCES

1. Yates JM, Logan EC, Stewart RM. Iron deficiency anemia in general practice: clinical outcomes over three years and factors influencing diagnostic investigations.Postgrad Med J 2004;80(945):405-10
2. Vahidinia AA, Shams S. Iron deficiency amongst nursing students.Indian J Med Sci 2004 Sep;58(9):389-93
3. Mehta BC. Iron deficiency amongst nursing students.Indian J Med Sci. 2004 Sep;58(9):389-93
4. Niv E, Elis A, Zissin R, Naftali T, Novis B, Lishner M. Iron deficiency anemia in patients without gastrointestinal symptoms--a prospective study.Fam Pract. 2005;22(1):58-61. Epub 2005 Jan 11
5. Chakrabarti P, Gupta R, Mishra A, Rai M, Pratap Singh V, Dash D. Spectrum of beta-thalassemia mutations in North Indian states: A beta-thalassemia trait with two mutations in cis.Clin Biochem 2005;38(6):576-8
6. Hernell O, Lonnerdal B. Is iron deficiency in infants and young children common in Scandinavia and is there a need for enforced primary prevention. Acta Paediatr 2004;93(8):1024-6
7. Lindsay H Allen, Anemia and iron deficiency: effects on pregnancy outcome, Am J Clin Nutr 2000;71(5 Suppl):1280S-4
8. Buonomo E, Cenko F, Altan AM, Godo A, Marazzi MC, Palombi L. Iron deficiency anemia and feeding practices in Albanian children.Ann Ig 2005;17(1):27-33
9. Verrall T, Gray-Donald K. Impact of a food-based approach to improve iron nutrition of at-risk infants in northern Canada.Prev Med 2005;40(6):896-903
10. Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. The effect of iron deficiency anemia on the function of the immune system.Hematol J 2005;5(7):579-83
11. Genc S, Erten N, Karan MA, et al. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients.Tohoku J Exp Med 2004;202(2):135-42

Copyright 2008 - European Journal of General Medicine

The following images related to this document are available:

Photo images